Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemRisk is a leading scientific consulting firm that specializes in toxicology, industrial hygiene, epidemiology, and risk assessment. The company provides technical advisory services to help clients characterize and manage the health and environmental risks associated with chemicals, pharmaceuticals, and consumer products. ChemRisk is widely recognized for its expertise in evaluating complex exposures and has played a significant role in high-profile litigation and regulatory matters involving human health. Following its acquisition by Cardno and subsequently Stantec, the team continues to offer specialized scientific support to the life sciences, legal, and industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChemRisk.